GE Healthcare to invest $50 million for Telemedicine advancement in Israel

GE Healthcare, a billion-dollar division of General Electric, agreed to invest upwards of $50 million in Israeli telemedicine business Pulsenmore.

Pulsenmore, founded in 2014, invented a self-operated prenatal portable ultrasound gadget. The service can be online clinician-guided or offline application-guided. The software allows pregnant women to book online consultations and obtain clinical assessments from remote healthcare specialists.

This funding will speed up the global acceptance of Pulsenmore's homecare ultrasound technologies and help the firm gain FDA certification and expand commercially.

GE Healthcare will join with Pulsenmore to commercialize its devices when they are launched. GE Healthcare will also work with Pulsenmore to increase ultrasound-based healthcare products for the homecare industry, which is estimated to reach $662.67 billion by 2027.

Pulsenmore's technology has been installed in Israel by Clalit Health Services, perhaps the largest HMO. As part of its 'virtual hospital' program, Israel's Sheba Medical Center uses the devices to conduct ultrasounds on migrants at the Ukraine border.

Pulsenmore Founder and chief executive Dr. Elazar Sonnenschein called the deal a sign of confidence in the company's ultrasound technology. “With GE Healthcare's market leadership and reach, we're one step closer to fulfilling our ambition of making home ultrasonography generally reachable for remote and dependable treatment, enhancing maternal health globally. Through this exciting alliance, we will enable women to proactively manage their pregnancy alongside their health care professionals and drive the next generation of ultrasound innovations that will benefit patients and clinicians alike.

“Healthcare providers foresee a considerable migration of care services from traditional institutions to the home by 2025,” said GE Healthcare Ultrasound president and Chief executive Roland Rott. Homecare offers payers, healthcare institutions, physician practices, and treatment at home providers the chance to improve patient care and experience. We're investing in Pulsenmore's homecare ultrasound technology for this reason. We are thrilled to introduce this extremely complementary product to our Women's Health Voluson as well as Primary Care Vscan ultrasonography diagnostics services, marking a big step forward towards enabling precision health.”